- Home
- FGEN vs IOTR Comparison
FGEN vs IOTR Comparison
Compare FGEN & IOTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- IOTR
- Stock Information
- Founded
- FGEN 1993
- IOTR 2019
- Country
- FGEN United States
- IOTR Singapore
- Employees
- FGEN N/A
- IOTR N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- IOTR
- Sector
- FGEN Health Care
- IOTR
- Exchange
- FGEN Nasdaq
- IOTR NYSE
- Market Cap
- FGEN 33.5M
- IOTR 29.5M
- IPO Year
- FGEN 2014
- IOTR 2025
- Fundamental
- Price
- FGEN $7.44
- IOTR $0.50
- Analyst Decision
- FGEN Strong Buy
- IOTR
- Analyst Count
- FGEN 1
- IOTR 0
- Target Price
- FGEN $250.00
- IOTR N/A
- AVG Volume (30 Days)
- FGEN 66.4K
- IOTR 324.4K
- Earning Date
- FGEN 08-05-2025
- IOTR 01-01-0001
- Dividend Yield
- FGEN N/A
- IOTR N/A
- EPS Growth
- FGEN N/A
- IOTR N/A
- EPS
- FGEN N/A
- IOTR N/A
- Revenue
- FGEN $6,996,000.00
- IOTR $10,478,550.00
- Revenue This Year
- FGEN N/A
- IOTR N/A
- Revenue Next Year
- FGEN N/A
- IOTR N/A
- P/E Ratio
- FGEN N/A
- IOTR N/A
- Revenue Growth
- FGEN N/A
- IOTR 22.27
- 52 Week Low
- FGEN $4.50
- IOTR $0.31
- 52 Week High
- FGEN $38.25
- IOTR $5.98
- Technical
- Relative Strength Index (RSI)
- FGEN 64.36
- IOTR N/A
- Support Level
- FGEN $7.03
- IOTR N/A
- Resistance Level
- FGEN $5.73
- IOTR N/A
- Average True Range (ATR)
- FGEN 0.50
- IOTR 0.00
- MACD
- FGEN 0.35
- IOTR 0.00
- Stochastic Oscillator
- FGEN 100.00
- IOTR 0.00
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.